GlassScriptPhysician profile
Rajiv A Patel
NPI 1063434314
$1,088.89
in general payments reported to CMS, 2019-2025
11 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.34 · 2020: $29.90 · 2022: $170 · 2023: $340 · 2024: $409 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $871.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $870.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $558.70 | 2023-2024 | Avvigo Guidance System |
| Sirtex Medical INC | $139.31 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $104.82 | 2025 | Farxiga |
| Abbott Laboratories | $82.96 | 2023 | Mitraclip |
| Takeda Pharmaceuticals U.S.A., INC. | $54.37 | 2023 | Glassia |
| Cvrx, INC. | $42.70 | 2022-2023 | Barostim Neo System |
| Amgen INC. | $29.90 | 2020 | |
| Janssen Pharmaceuticals, INC | $20.37 | 2023 | Xarelto |
| Genentech USA, INC. | $19.97 | 2023 | Vabysmo |
| Therapeuticsmd, INC. | $18.34 | 2019 | |
| Novo Nordisk INC | $17.45 | 2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajiv Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.